Drug Type CAR-NK |
Synonyms- |
Target- |
Mechanism Gene transference, Natural killer cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization CoImmune, Inc.Startup |
Active Organization CoImmune, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | - | CoImmune, Inc.Startup | - |